✨ Your Portfolio is fetched and updated from zerodha.
Small Hospitals

Suraksha Diagnostic Ltd.

SURAKSHA

Market Cap
₹1,621 Cr.
P/E
68.62

Suraksha Diagnostic Ltd.

About
Suraksha Diagnostic provides comprehensive pathology and radiology testing services along with medical consultations, X-rays, ultrasonography, CT scans, MRI scans, and vaccination services. They also … Read more
Suraksha Diagnostic provides comprehensive pathology and radiology testing services along with… Read more
Low
231
52W Range
High
449
  • Suraksha Diagnostic
  • Dr. Lal Pathlabs
  • Metropolis Health.
  • TJI Diagnostic Chains

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

3 No

Negative for this company

2 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Customer Segment

Operational Metrics

    locked
    Select a Metric
    • Realization/Patient - Diagnostic Centres (Rs/Patient)
      Source
    • Number of Daily Patients - Diagnostic Centres (Ths)
      Source
    • Operating Margin/Test - Diagnostic Centres (Rs/Test)
      Source
    • No of Tests - Quarterly (Mn)
      Source
    Peer Comparison
    FAQs on Suraksha Diagnostic Ltd. Business

    Suraksha Diagnostic offers one-stop integrated solutions for pathology and radiology testing and medical consultation services including X-rays, ultrasonography, computerized tomography, magnetic resonance imaging scans and vaccination services. In addition to integrated pathology and radiology testing services, it also offers omnichannel medical consultation services via online and offline modes to its customers.

    Suraksha Diagnostic major competitors are Dr. Lal Pathlabs, Metropolis Health., Thyrocare Tech., Vijaya Diagnostic.
    Market Cap of Suraksha Diagnostic is ₹1,621 Crs.
    While the median market cap of its peers are ₹10,254 Crs.

    Suraksha Diagnostic seems to be less financially stable compared to its competitors.
    Altman Z score of Suraksha Diagnostic is 10.07 and is ranked 5 out of its 5 competitors.

    View FAQ's On Shareprice
    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Sep Dec
    Investor Presentation Sep Dec
    Conference Call Sep Dec
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Hospital Sector
    The Business Model of Indian Hospitals Simplified - Anish Moonka
    Effect Of Lease Accounting Changes & Why Debt To Equity Is Rising - SOIC
    Case Mix Of Hospitals - Harshit Toshniwal
    Hospital Sector Deep Dive! Part 2 - Who pays our bills? Payor mix, Profitability of payor types - Harshit Toshniwal
    Hospital Sector Deep Dive! Part 3 - Unit Economics, IRR of Hospital bus., Doctor Engagement Models - Harshit Toshniwal
    Hospital Sector Deep Dive! Part 7 - Stock preference in India Hospital Space - Harshit Toshniwal
    Medical Costs - India vs Abroad - Trade Brains
    A thread on the Medical Tourism in India - Aditya Kondawar
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material